Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges, including declining cigarette volumes and e-vapor headwinds.
Trump announces tariff cuts with China after successful talks, signaling progress in trade negotiations and potential for further cooperation.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges, including declining cigarette volumes and e-vapor headwinds.
Trump announces tariff cuts with China after successful talks, signaling progress in trade negotiations and potential for further cooperation.